| Literature DB >> 18635000 |
Abstract
Aptamers, sometimes termed "chemical antibodies," have been engineered into multimerized versions for therapeutic application. The groups of Gilboa and Sullenger now report the development of a bivalent aptamer-molecular device as a receptor agonist that has the same functional properties, but stronger avidity than a corresponding antibody.Mesh：
Substances：
Year: 2008 PMID： 18635000 DOI： 10.1016/j.chembiol.2008.07.004
Source DB: PubMed Journal: Chem Biol ISSN： 1074-5521